|Mr. Gary R. Maharaj||CEO, Pres & Director||1.33M||2.68M||1963|
|Mr. Timothy J. Arens||Chief Financial Officer||423.63k||1.76M||1967|
|Mr. Bryan K. Phillips||Sr. VP of Legal, HR & Information Technology, Gen. Counsel and Sec.||587.94k||366.62k||1971|
|Mr. Thomas A. Greaney||Chief Operating Officer of Medical Devices||596.9k||N/A||1966|
|Mr. Gregg S. Sutton||VP of R&D - Medical Devices||489.9k||794.15k||1960|
Surmodics, Inc., together with its subsidiaries, provides medical devices and in vitro diagnostic technologies to the healthcare industry in the United States and internationally. The company operates through two segments, Medical Device and In Vitro Diagnostics. The Medical Device segment designs, develops, and manufactures interventional medical devices primarily for the peripheral vascular market; and offers surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device for the coronary, peripheral, neuro-vascular, urology, and other markets. The Vitro Diagnostics segment provides stabilization products, substrates, antigens, and surface coatings to diagnostics customers; and manufactures or sells components for in vitro diagnostic immunoassay and molecular tests, as well as surface coatings to the diagnostic, biomedical research, and life science markets. Surmodics, Inc. was founded in 1979 and is headquartered in Eden Prairie, Minnesota.
Surmodics, Inc.’s ISS Governance QualityScore as of July 29, 2019 is 4. The pillar scores are Audit: 3; Board: 1; Shareholder Rights: 5; Compensation: 5.